These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27873046)

  • 21. Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
    Harmsen MG; Arts-de Jong M; Hoogerbrugge N; Maas AH; Prins JB; Bulten J; Teerenstra S; Adang EM; Piek JM; van Doorn HC; van Beurden M; Mourits MJ; Zweemer RP; Gaarenstroom KN; Slangen BF; Vos MC; van Lonkhuijzen LR; Massuger LF; Hermens RP; de Hullu JA
    BMC Cancer; 2015 Aug; 15():593. PubMed ID: 26286255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
    Schrag D; Kuntz KM; Garber JE; Weeks JC
    N Engl J Med; 1997 May; 336(20):1465-71. PubMed ID: 9148160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
    Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
    N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial.
    Simkin-Silverman LR; Wing RR; Boraz MA; Kuller LH
    Ann Behav Med; 2003 Dec; 26(3):212-20. PubMed ID: 14644697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
    JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.
    Garcia C; Lyon L; Conell C; Littell RD; Powell CB
    Gynecol Oncol; 2015 Sep; 138(3):723-6. PubMed ID: 26086567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
    N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.
    Schrauder MG; Brunel-Geuder L; Häberle L; Wunderle M; Hoyer J; Reis A; Schulz-Wendtland R; Beckmann MW; Lux MP
    Breast; 2017 Apr; 32():186-191. PubMed ID: 28214786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers - an interventional randomized controlled multicenter trial (LIBRE-1).
    Kiechle M; Dukatz R; Yahiaoui-Doktor M; Berling A; Basrai M; Staiger V; Niederberger U; Marter N; Lammert J; Grill S; Pfeifer K; Rhiem K; Schmutzler RK; Laudes M; Siniatchkin M; Halle M; Bischoff SC; Engel C
    BMC Cancer; 2017 Nov; 17(1):752. PubMed ID: 29126396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic oophorectomy in women at increased cancer risk.
    Domchek SM; Rebbeck TR
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study.
    Harrigan M; Cartmel B; Loftfield E; Sanft T; Chagpar AB; Zhou Y; Playdon M; Li F; Irwin ML
    J Clin Oncol; 2016 Mar; 34(7):669-76. PubMed ID: 26598750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins.
    Schmitz KH; Ahmed RL; Hannan PJ; Yee D
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1672-80. PubMed ID: 16030100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial of two mail-based lifestyle interventions for breast cancer survivors.
    Park CL; Cho D; Salner AL; Dornelas E
    Support Care Cancer; 2016 Jul; 24(7):3037-46. PubMed ID: 26887585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors.
    Demark-Wahnefried W; Clipp EC; Lipkus IM; Lobach D; Snyder DC; Sloane R; Peterson B; Macri JM; Rock CL; McBride CM; Kraus WE
    J Clin Oncol; 2007 Jul; 25(19):2709-18. PubMed ID: 17602076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight lifting and appendicular skeletal muscle mass among breast cancer survivors: a randomized controlled trial.
    Brown JC; Schmitz KH
    Breast Cancer Res Treat; 2015 Jun; 151(2):385-92. PubMed ID: 25935584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet.
    Thomson CA; Rock CL; Giuliano AR; Newton TR; Cui H; Reid PM; Green TL; Alberts DS;
    Eur J Nutr; 2005 Feb; 44(1):18-25. PubMed ID: 15309460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk of BRCA1/2 mutation carriers: A review.
    van Westerop LL; Arts-de Jong M; Hoogerbrugge N; de Hullu JA; Maas AH
    Maturitas; 2016 Sep; 91():135-9. PubMed ID: 27451331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
    Fakkert IE; Jansen L; Meijer K; Kok T; Oosterwijk JC; Mourits MJ; de Bock GH
    Breast Cancer Res Treat; 2011 Aug; 129(1):157-64. PubMed ID: 21373873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.